Published in Ann Rheum Dis on May 05, 2005
Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study. Mod Rheumatol (2008) 1.40
Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study). Mod Rheumatol (2011) 1.04
Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. Rheumatol Int (2012) 1.02
Lipid-derived free radical production in superantigen-induced interstitial pneumonia. Free Radic Biol Med (2009) 0.85
[Immune senescence and autoimmunity. Does the immune system really age, or just the organs which supply it?]. Z Rheumatol (2011) 0.75
Length of life and cause of death in rheumatoid arthritis. N Engl J Med (1953) 7.62
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. Ann Rheum Dis (1964) 5.80
Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol (1997) 3.65
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum (2002) 3.53
Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum (2003) 3.35
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum (1984) 3.33
Diagnostic criteria for population studies. Bull Rheum Dis (1962) 3.23
Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum (1986) 2.55
All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol (2003) 2.52
Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum (2003) 2.48
Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis (1999) 2.12
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) (1985) 2.10
Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol (1999) 2.07
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol (1998) 2.00
Mortality among arthritics. J Chronic Dis (1976) 1.85
Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scand J Rheumatol (1981) 1.72
Increased mortality in rheumatoid arthritis. Scand J Rheumatol (1982) 1.67
Survivorship and death in rheumatoid arthritis. Arthritis Rheum (1970) 1.66
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57
National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol (2003) 1.56
Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum (1993) 1.52
No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis (2000) 1.40
Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol (2000) 1.24
Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study. Ann Rheum Dis (2002) 1.21
Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis (1990) 1.21
Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.20
Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis (2002) 1.14
Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatol Suppl (2004) 1.09
Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years. Scand J Rheumatol (1999) 0.94
Rheumatoid arthritis and gout in Hiroshima and Nagasaki, Japan. A prevalence and incidence study. J Chronic Dis (1971) 0.94
Rheumatoid arthritis in Hiroshima and Nagasaki, Japan. Prevalence, incidence, and clinical characteristics. Arthritis Rheum (1967) 0.86
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology (1990) 11.22
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol (2001) 4.96
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
Complete genomic sequence of the filamentous nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120. DNA Res (2001) 4.27
Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science (2001) 4.13
The dinB gene encodes a novel E. coli DNA polymerase, DNA pol IV, involved in mutagenesis. Mol Cell (1999) 4.01
The site of action and active form of local anesthetics. II. Experiments with quaternary compounds. J Pharmacol Exp Ther (1970) 3.59
Signal transduction in the phosphate regulon of Escherichia coli involves phosphotransfer between PhoR and PhoB proteins. J Mol Biol (1989) 3.56
Multiple pathways for SOS-induced mutagenesis in Escherichia coli: an overexpression of dinB/dinP results in strongly enhancing mutagenesis in the absence of any exogenous treatment to damage DNA. Proc Natl Acad Sci U S A (1997) 3.53
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med (2001) 3.36
virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence. J Bacteriol (1989) 3.31
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol (1987) 3.30
Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J Bacteriol (1988) 3.24
Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun (1989) 3.09
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J Biol Chem (1996) 2.99
The S receptor kinase determines self-incompatibility in Brassica stigma. Nature (2000) 2.96
Murein-lipoprotein of Escherichia coli: a protein involved in the stabilization of bacterial cell envelope. Mol Gen Genet (1978) 2.84
cDNA cloning, sequence, and expression of carbonic anhydrase in Chlamydomonas reinhardtii: regulation by environmental CO2 concentration. Proc Natl Acad Sci U S A (1990) 2.71
Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature (1996) 2.70
High-efficiency transformation of Chlamydomonas reinhardtii by electroporation. Genetics (1998) 2.66
Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J Ethnopharmacol (1996) 2.57
Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci (2001) 2.54
The pollen determinant of self-incompatibility in Brassica campestris. Proc Natl Acad Sci U S A (2000) 2.50
Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta. J Immunol (1986) 2.49
A spin-valve-like magnetoresistance of an antiferromagnet-based tunnel junction. Nat Mater (2011) 2.47
Nucleotide sequence of the asnA gene coding for asparagine synthetase of E. coli K-12. Nucleic Acids Res (1981) 2.42
Three-dimensional structure of interleukin 8 in solution. Biochemistry (1990) 2.40
Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol (1997) 2.38
Maternal Pumilio acts together with Nanos in germline development in Drosophila embryos. Nat Cell Biol (1999) 2.35
Gene organization in the region containing a new gene involved in chromosome partition in Escherichia coli. J Bacteriol (1988) 2.31
Roles of chromosomal and episomal dinB genes encoding DNA pol IV in targeted and untargeted mutagenesis in Escherichia coli. Mol Genet Genomics (2001) 2.31
TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med (2000) 2.29
Temporal and tissue-specific expression of mouse ets genes. Proc Natl Acad Sci U S A (1987) 2.20
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Species-specific in vitro synthesis of DNA containing the polyoma virus origin of replication. Proc Natl Acad Sci U S A (1986) 2.16
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Nucleotide sequence of the structural gene for colicin E1 and predicted structure of the protein. Proc Natl Acad Sci U S A (1982) 2.15
High serum levels of M-CSF and G-CSF in Kawasaki disease. Br J Haematol (1999) 2.14
The site of action and active form of local anesthetics. I. Theory and pH experiments with tertiary compounds. J Pharmacol Exp Ther (1970) 2.13
Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat Cell Biol (2000) 2.12
Fukuyama-type congenital muscular dystrophy and the Walker-Warburg syndrome. Brain Dev (1993) 2.08
Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol (1991) 2.07
Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor. Nucleic Acids Res (1985) 2.06
A simple tool to identify asian women at increased risk of osteoporosis. Osteoporos Int (2001) 2.06
Diagnosis and management of heterotopic pancreas. Int Surg (1993) 2.04
Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. Proc Natl Acad Sci U S A (1990) 1.96
Essential role of the posterior morphogen nanos for germline development in Drosophila. Nature (1996) 1.96
Complete nucleotide sequence of the gene for human interleukin 1 alpha. Nucleic Acids Res (1986) 1.95
Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development (2001) 1.95
Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). J Biol Chem (1999) 1.93
"Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta. Proc Natl Acad Sci U S A (1985) 1.93
A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol (1991) 1.93
Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci U S A (1991) 1.92
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92
Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet (1998) 1.91
The nucleoids of rat liver cell microbodies. Fine structure and enzymes. J Cell Biol (1966) 1.89
Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity (1997) 1.89
A novel ATP-dependent inward rectifier potassium channel expressed predominantly in glial cells. J Biol Chem (1995) 1.81
Glucitol-specific enzymes of the phosphotransferase system in Escherichia coli. Nucleotide sequence of the gut operon. J Biol Chem (1987) 1.80
Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane. Eur J Biochem (1984) 1.77
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest (2000) 1.76
HeLa cell DNA polymerase gamma: further purification and properties of the enzyme. Biochemistry (1976) 1.76
PAX6 missense mutation in isolated foveal hypoplasia. Nat Genet (1996) 1.76
Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol (1995) 1.76
Purification and initial characterization of a protein which facilitates assembly of nucleosome-like structure from mammalian cells. Eur J Biochem (1984) 1.71
Evaluation of the pharyngeal airway in patients with sleep apnea: value of ultrafast MR imaging. AJR Am J Roentgenol (1993) 1.71
Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem (2001) 1.70
A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet (1999) 1.69
Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology (2008) 1.69
A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2001) 1.68
Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol (1999) 1.66
Neuromagnetic evidence of pre- and post-central cortical sources of somatosensory evoked responses. Electroencephalogr Clin Neurophysiol (1996) 1.65
Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene (1990) 1.65
Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol (1989) 1.65
Production of friend leukemia virus in a mouse lung cell line. Jpn J Med Sci Biol (1967) 1.64
Extrahepatic portosystemic venous shunt without portal hypertension. Intern Med (1997) 1.64
Sugar permeases of the bacterial phosphoenolpyruvate-dependent phosphotransferase system: sequence comparisons. FASEB J (1988) 1.64
Decreased magnitude of heart rate spectral components in coronary artery disease. Its relation to angiographic severity. Circulation (1990) 1.64
Nidogen: a new, self-aggregating basement membrane protein. Eur J Biochem (1983) 1.62
Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol (2007) 1.61
Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease. Neurology (1998) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Calmodulin mediates calcium-dependent inactivation of the cerebellar type 1 inositol 1,4,5-trisphosphate receptor. Neuron (1999) 1.59
Gastric carcinoma in patients over 70 years of age. Br J Surg (1995) 1.59
Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res (1998) 1.57
A unique chitinase with dual active sites and triple substrate binding sites from the hyperthermophilic archaeon Pyrococcus kodakaraensis KOD1. Appl Environ Microbiol (1999) 1.56
Association of lack of cell wall teichuronic acid with formation of cell packets of Micrococcus lysodeikticus (luteus) mutants. J Bacteriol (1975) 1.56
Temporal and spatial variations in structural protein expression during the progression from stunned to hibernating myocardium. Circulation (2004) 1.56
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant (2003) 1.55
Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan. Osteoporos Int (2008) 1.55
Virulence-associated chromosomal loci of Shigella flexneri identified by random Tn5 insertion mutagenesis. Mol Microbiol (1991) 1.54
RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.54